IRON – disc medicine, inc. (US:NASDAQ)
Stock Stats
News
Auregen Biotherapeutics Announces Appointment of Scott Lauder, Ph.D., as Chief Technology Officer [Yahoo! Finance]
Disc Medicine, Inc. (NASDAQ: IRON) had its price target raised by analysts at Cantor Fitzgerald from $99.00 to $132.00. They now have an "overweight" rating on the stock.
Disc Medicine, Inc. (NASDAQ: IRON) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $85.00 price target on the stock.
Disc Medicine, Inc. (NASDAQ: IRON) had its price target raised by analysts at Scotiabank from $73.00 to $75.00. They now have a "sector outperform" rating on the stock.
Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Form 4 Disc Medicine, Inc. For: Mar 24 Filed by: Ashiya Mona
Form 4 Disc Medicine, Inc. For: Mar 24 Filed by: OrbiMed Capital GP VIII LLC
Form 4 Disc Medicine, Inc. For: Mar 19 Filed by: Ashiya Mona
Form 4 Disc Medicine, Inc. For: Mar 19 Filed by: ORBIMED ADVISORS LLC
Form 4 Disc Medicine, Inc. For: Mar 10 Filed by: Ashiya Mona
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.